Compulsive eating behaviors in Parkinson's disease.


Journal

Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 31 08 2018
accepted: 24 01 2019
pubmed: 5 2 2019
medline: 4 12 2019
entrez: 5 2 2019
Statut: ppublish

Résumé

Eating disorders are common in Parkinson's disease (PD) patients and often class in Impulse control disorders, however, little is known about their phenomenology. Specific symptoms and comorbidities were described in a group of PD patients in this preliminary study. Over a period of 6 months, 51 PD patients who experienced significant changes in eating habits following diagnosis of PD and were interviewed during regularly scheduled follow-up visits. We assessed each patient's height and weight, impulsivity, psychological distress, current eating disorder symptoms, food addiction, food habits and craving. Among the PD patients who experienced modified dietary habits following diagnosis, few exhibited binge eating disorders (BED) full criteria (3.9%). However, 21.6% of patients experienced episodes of out-of-control eating with a large quantity of food in short time and 39.2% satisfied food addiction (FA) criteria without binge eating disorder. Food cravings more than once a week were experienced in approximately half of the population including all FA patients. Regarding comorbidities, FA PD patients present impulsive features and anxiety. This study confirms the existence of FA profile in PD patients. Eating disorders even in PD are complex and have a cross-cutting criteria related to out-of-control eating, FA, and BED. The association of anxiety with PD-related food addiction, contrary to L-dopa equivalent daily dose mean score or the presence of dopamine agonists, underline the complex sustainability of the dopaminergic brainstem support. A study on their detailed prevalence in this population could be helpful to better understand unspecified feeding or eating disorder. DR-2012-007. French Committee for the Protection of Persons (CPP) & French National Commission on Computing and Liberty (CNIL). Level V, descriptive study.

Identifiants

pubmed: 30715681
doi: 10.1007/s40519-019-00648-1
pii: 10.1007/s40519-019-00648-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-429

Références

Ann Neurol. 2003 May;53(5):676-9
pubmed: 12731005
J Psychiatry Neurosci. 2004 Mar;29(2):134-7
pubmed: 15069467
Curr Opin Neurol. 2004 Aug;17(4):393-8
pubmed: 15247533
Mov Disord. 2006 Apr;21(4):524-9
pubmed: 16261618
Obes Res. 1993 Jul;1(4):306-24
pubmed: 16350580
Clin Ther. 2006 Jan;28(1):1-12
pubmed: 16490575
Arch Neurol. 2007 Aug;64(8):1089-96
pubmed: 17698698
Neurocase. 2008;14(6):480-4
pubmed: 19012168
J Psychiatr Res. 2009 Sep;43(14):1125-32
pubmed: 19427647
Parkinsonism Relat Disord. 2010 Mar;16(3):202-7
pubmed: 20018549
Appetite. 2010 Jun;54(3):473-9
pubmed: 20138944
Arch Intern Med. 2010 Apr 26;170(8):699-703
pubmed: 20421555
Arch Neurol. 2010 May;67(5):589-95
pubmed: 20457959
Ann Neurol. 2011 Jun;69(6):986-96
pubmed: 21416496
Front Psychiatry. 2011 Feb 21;2:1
pubmed: 21556272
Parkinsonism Relat Disord. 2011 Dec;17(10):740-4
pubmed: 21856206
Appetite. 2011 Dec;57(3):711-7
pubmed: 21907742
Curr Drug Abuse Rev. 2011 Sep;4(3):174-81
pubmed: 21999691
Curr Drug Abuse Rev. 2011 Sep;4(3):201-7
pubmed: 21999695
Neuropharmacology. 2012 Jul;63(1):87-96
pubmed: 22138162
Psychogeriatrics. 2011 Dec;11(4):247-8
pubmed: 22151246
Neurology. 2013 Jan 8;80(2):176-80
pubmed: 23296128
Appetite. 2013 Aug;67:22-4
pubmed: 23535004
Ther Adv Neurol Disord. 2013 May;6(3):175-88
pubmed: 23634190
Physiol Behav. 2013 Jun 13;118:63-9
pubmed: 23680433
Nat Rev Neurosci. 2014 Jun;15(6):367-78
pubmed: 24840801
Lancet. 2014 Aug 9;384(9942):532-44
pubmed: 24954673
Mol Psychiatry. 2014 Oct;19(10):1078-84
pubmed: 25199919
Mov Disord. 2015 Feb;30(2):121-7
pubmed: 25370355
Mov Disord. 2015 Feb;30(2):141-9
pubmed: 25476402
Front Psychiatry. 2014 Nov 19;5:164
pubmed: 25477827
Nutrients. 2014 Dec 31;7(1):223-38
pubmed: 25558907
PLoS One. 2015 Feb 18;10(2):e0117959
pubmed: 25692302
Nutr Rev. 2015 May;73(5):296-307
pubmed: 26011903
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S101-5
pubmed: 26298389
J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):864-70
pubmed: 26534930
Front Behav Neurosci. 2015 Nov 30;9:317
pubmed: 26648853
J Behav Addict. 2016 Mar;5(1):140-143
pubmed: 26690325
Physiol Behav. 2016 Apr 1;157:28-38
pubmed: 26812591
Psychol Addict Behav. 2016 Feb;30(1):113-21
pubmed: 26866783
Clin Psychol Rev. 2016 Mar;44:125-139
pubmed: 26879210
Int J Obes (Lond). 2016 Mar;40 Suppl 1:S12-21
pubmed: 27001642
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1106-11
pubmed: 27076492
Appetite. 2016 Oct 1;105:172-9
pubmed: 27230611
Front Psychiatry. 2016 May 30;7:91
pubmed: 27303314
Yale J Biol Med. 2016 Mar 24;89(1):37-47
pubmed: 27505015
Neurology. 2016 Oct 4;87(14):1436-1441
pubmed: 27590295
J Parkinsons Dis. 2017;7(1):183-191
pubmed: 27911342
Eat Weight Disord. 2017 Mar;22(1):49-59
pubmed: 27943202
Lancet Neurol. 2017 Mar;16(3):238-250
pubmed: 28229895
J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):317-324
pubmed: 28315845
Semin Neurol. 2017 Apr;37(2):186-192
pubmed: 28511259
Drug Saf. 2018 Jan;41(1):19-75
pubmed: 28861870
J Photochem Photobiol B. 2017 Oct;175:109-124
pubmed: 28865316
Neuroimage Clin. 2017 Aug 24;16:455-460
pubmed: 28879087
Mov Disord. 2017 Sep;32(9):1264-1310
pubmed: 28887905
Int J Neuropsychopharmacol. 2018 Jan 1;21(1):42-58
pubmed: 29036632
Cell Tissue Res. 2018 Jul;373(1):327-336
pubmed: 29383446
Nutrients. 2018 Apr 12;10(4):null
pubmed: 29649120
Front Neurol. 2018 Aug 28;9:654
pubmed: 30233478
PLoS One. 2018 Oct 2;13(10):e0205100
pubmed: 30278074
Am J Psychiatry. 2019 Jan 1;176(1):5-11
pubmed: 30848949
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124

Auteurs

Ingrid de Chazeron (I)

Service de Psychiatrie B, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, Rue Montalembert BP 69, 63003, Clermont-Ferrand, France. idechazeron@chu-clermontferrand.fr.

Franck Durif (F)

Service de neurologie A, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.

Isabelle Chereau-Boudet (I)

Service de Psychiatrie B, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, Rue Montalembert BP 69, 63003, Clermont-Ferrand, France.

Maria Livia Fantini (ML)

Service de neurologie A, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.

Ana Marques (A)

Service de neurologie A, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.

Philippe Derost (P)

Service de neurologie A, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.

Berengere Debilly (B)

Service de neurologie A, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, France.

Georges Brousse (G)

Service de Psychiatrie B, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, Rue Montalembert BP 69, 63003, Clermont-Ferrand, France.

Yves Boirie (Y)

Service de nutrition clinique, CHU Clermont-Ferrand, INRA, UMR 1019, UNH, CRNH Auvergne, Clermont-Ferrand, France.

Pierre Michel Llorca (PM)

Service de Psychiatrie B, CHU Clermont-Ferrand, EA7280, Université Clermont Auvergne, Clermont-Ferrand, Rue Montalembert BP 69, 63003, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH